➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Medtronic
Baxter
McKesson
Dow
AstraZeneca
Colorcon

Last Updated: May 11, 2021

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR NAROPIN

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

All Clinical Trials for Naropin

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00562627 Efficacy of Multimodal Peri- and Intraarticular Drug Injections in Total Knee Arthroplasty Completed Asker & Baerum Hospital Phase 4 2007-11-01 Total knee arthroplasty (TKA) is associated with moderate to severe postoperative pain, causing patient discomfort, mobilisation and hospital discharge. The aim of this study is to: 1. Compare analgetic efficacy of to types of local infiltration analgesia in total knee arthroplasty. 2. Compare analgetic efficacy of local infiltration analgesia with continuous epidural analgesia.
NCT00573963 Efficacy of the Transversus Abdominus Plane (TAP) Block for Post-Cesarean Delivery Analgesia Completed Samuel Lunenfeld Research Institute, Mount Sinai Hospital N/A 2007-12-01 The purpose of this study is to determine if patients having the transversus abdominal place (TAP) block at the end of a cesarean delivery have less pain in the post-delivery period than those who do not. Freezing medication is injected between the layers of muscle on either side of the belly, to freeze the nerves that carry pain stimuli from an abdominal wound. This technique has been useful for many abdominal operations, and has recently been studied in cesarean sections, however more information is needed.
NCT00603083 Postoperative Pain Treatment in Total Hip Arthroplasty: A Study to Assess the Effect of Local Analgesia Completed Vejle Hospital Phase 4 2008-01-01 The purpose of this study is to determine whether the investigator standardized pain treatment plus local pain treatment is more effective than the investigator standardized pain treatment plus placebo in total hip arthroplasty.
NCT00702416 Ultrasound Guidance for Interscalene Brachial Plexus Block Completed University of Parma Phase 4 2008-05-01 This study has been designed to assess the possible advantages of using ultrasound imaging to block the brachial plexus (i.e., nerves of the upper limb) in patients undergoing shoulder surgery. The ultrasound technique will be compared with the current gold standard, electrical nerve stimulation. The aim of this study is to define which technique is better in terms of time to onset of anesthesia.
NCT00724035 Ultrasound-Guided Axillary or Infraclavicular Nerve Block for Upper Limb Surgery Completed University of Parma Phase 4 2008-05-01 This study aims to detect differences in onset time of brachial plexus (i.e., arm) anesthesia using two different nerve block techniques. Using ultrasound guidance, axillary (i.e., at the armpit) and infraclavicular (i.e., below the collarbone) blocks will be performed to patients undergoing upper limb surgery. The investigators will analyze how long it takes for anesthesia to be adequate for pain-free surgery, thus determine the optimal technique for this kind of surgery.
NCT00868348 A Comparison of Naropin and Ketorolac for Postoperative Analgesia After Total Knee Arthroplasty Completed University of Aarhus Phase 4 2009-05-01 The purpose of this study is to determine wether ketorolac is effective in the treatment of postoperative pain after total knee arthroplasty
NCT00987441 Epidural Labor Analgesia and Infant Neurobehavior Completed Nanjing Medical University N/A 2009-09-01 Infant neurobehavior alteration is predictor of later intelligence development. Many factors would influence or are associated with infant neurobehavior, of which exist or appear during perinatal period. Neuraxial, especially epidural, analgesia to date is the most effective method in relieving labor pain. Although previous studies showed that opioid used in epidural analgesia for labor pain can affect newborn neurobehavior negatively in a dose-escalation associated manner, whether epidural analgesia itself would produce unpredictable effect on newborn neurobehavior is still unknown. Hereby the investigators designed this trial to investigate the hypothesis that epidural analgesia for labor pain control itself would not produce negative effect on infant neurobehavior.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Naropin

Condition Name

Condition Name for Naropin
Intervention Trials
Pain, Postoperative 21
Postoperative Pain 16
Pain 16
Anesthesia 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Naropin
Intervention Trials
Pain, Postoperative 40
Osteoarthritis 11
Osteoarthritis, Knee 7
Fractures, Bone 6
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Naropin

Trials by Country

Trials by Country for Naropin
Location Trials
United States 53
Denmark 14
Canada 13
China 9
Singapore 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Naropin
Location Trials
Ohio 6
Florida 4
Texas 4
Michigan 3
Massachusetts 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Naropin

Clinical Trial Phase

Clinical Trial Phase for Naropin
Clinical Trial Phase Trials
Phase 4 59
Phase 3 19
Phase 2/Phase 3 2
[disabled in preview] 12
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Naropin
Clinical Trial Phase Trials
Completed 52
Recruiting 37
Not yet recruiting 25
[disabled in preview] 21
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Naropin

Sponsor Name

Sponsor Name for Naropin
Sponsor Trials
Boston Children’s Hospital 5
Duke University 4
University of Florida 3
[disabled in preview] 12
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Naropin
Sponsor Trials
Other 174
Industry 11
U.S. Fed 4
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Colorcon
Moodys
Merck
Express Scripts
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.